scholarly journals Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS

Bioanalysis ◽  
2014 ◽  
Vol 6 (11) ◽  
pp. 1471-1485 ◽  
Author(s):  
Adarsh S Gandhi ◽  
Mingshe Zhu ◽  
Shaokun Pang ◽  
Ariane Wohlfarth ◽  
Karl B Scheidweiler ◽  
...  
2020 ◽  
Vol 22 (1) ◽  
pp. 230
Author(s):  
Jeremy Carlier ◽  
Xingxing Diao ◽  
Raffaele Giorgetti ◽  
Francesco P. Busardò ◽  
Marilyn A. Huestis

For more than ten years, new synthetic cathinones (SCs) mimicking the effects of controlled cocaine-like stimulants have flooded the illegal drug market, causing numerous intoxications and fatalities. There are often no data on the pharmacokinetics of these substances when they first emerge onto the market. However, the detection of SC metabolites is often critical in order to prove consumption in clinical and forensic settings. In this research, the metabolite profile of two pyrrolidinyl SCs, α-pyrrolidinohexaphenone (α-PHP) and 4′′-fluoro-α-pyrrolidinovalerophenone (4F-α-PVP), were characterized to identify optimal intake markers. Experiments were conducted using pooled human hepatocyte incubations followed by liquid chromatography–high-resolution tandem mass spectrometry and data-mining software. We suggest α-PHP dihydroxy-pyrrolidinyl, α-PHP hexanol, α-PHP 2′-keto-pyrrolidinyl-hexanol, and α-PHP 2′-keto-pyrrolidinyl as markers of α-PHP use, and 4F-α-PVP dihydroxy-pyrrolidinyl, 4F-α-PVP hexanol, 4F-α-PVP 2′-keto-pyrrolidinyl-hexanol, and 4F-α-PVP 2′-keto-pyrrolidinyl as markers of 4F-α-PVP use. These results represent the first data available on 4F-α-PVP metabolism. The metabolic fate of α-PHP was previously studied using human liver microsomes and urine samples from α-PHP users. We identified an additional major metabolite (α-PHP dihydroxy-pyrrolidinyl) that might be crucial for documenting exposure to α-PHP. Further experiments with suitable analytical standards, which are yet to be synthesized, and authentic specimens should be conducted to confirm these results.


2017 ◽  
Vol 415 ◽  
pp. 63-84 ◽  
Author(s):  
Jie Peng ◽  
Yang Zhao ◽  
Lu Xu ◽  
Li-ping Kang ◽  
Jiang-ming Cui ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-9
Author(s):  
Yanjie Yang ◽  
Dehui Xu ◽  
Ning Ning ◽  
Yujing Xu

Cold atmospheric plasma (CAP) is a novel technology, which has been widely applied in biomedicine, especially in wound healing, dermatological treatment, hemostasis, and cancer treatment. In most cases, CAP treatment will interact with innumerable blood capillaries. Therefore, it is important and necessary to understand the effects of CAP treatment on endothelial cell metabolism. In this study, the metabolite profiling of plasma treatment on endothelial cells was measured by gas chromatography tandem time-of-flight mass spectrometry (GC-TOF-MS). We found that 695 signals (metabolites) were detected by GC-TOF-MS and then evaluated using orthogonal projections to latent structures discriminant analysis (OPLS-DA). All the differential metabolites were listed, and proline and xanthosine were the two of the most downregulated metabolites by plasma treatment. By comprehensive metabolic pathway analysis with the KEGG pathway, we showed that alanine, aspartate, glutamate, and purine metabolism pathways were the most significantly suppressed after gas plasma treatment in human endothelial cells. Our finding gives an overall picture of the metabolic pathways affected by plasma treatment in endothelial cells.


2015 ◽  
Vol 63 (32) ◽  
pp. 7169-7179 ◽  
Author(s):  
Timo D. Stark ◽  
Sofie Lösch ◽  
Junichiro Wakamatsu ◽  
Onesmo B. Balemba ◽  
Oliver Frank ◽  
...  

2015 ◽  
Vol 13 (2) ◽  
pp. 145-160 ◽  
Author(s):  
Xiao-Wei LIU ◽  
Feng ZHANG ◽  
Shou-Hong GAO ◽  
Bo JIANG ◽  
Wan-Sheng CHEN
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document